RU95120819A - EXTERNAL MEANS AND METHOD OF TREATMENT OF NEUROLOGICAL DISEASES AND DISEASES OF THE MOTOR-MOTOR APPARATUS WITH PAIN SYNDROME AND Puffiness - Google Patents

EXTERNAL MEANS AND METHOD OF TREATMENT OF NEUROLOGICAL DISEASES AND DISEASES OF THE MOTOR-MOTOR APPARATUS WITH PAIN SYNDROME AND Puffiness

Info

Publication number
RU95120819A
RU95120819A RU95120819/14A RU95120819A RU95120819A RU 95120819 A RU95120819 A RU 95120819A RU 95120819/14 A RU95120819/14 A RU 95120819/14A RU 95120819 A RU95120819 A RU 95120819A RU 95120819 A RU95120819 A RU 95120819A
Authority
RU
Russia
Prior art keywords
diseases
motor
treatment
puffiness
pain syndrome
Prior art date
Application number
RU95120819/14A
Other languages
Russian (ru)
Other versions
RU2101015C1 (en
Inventor
Т.А. Матковская
Е.В. Хоженко
Э.А. Юрьева
Л.Н. Олешко
Р.С. Мегдятов
С.А. Козлов
Н.П. Демина
А.Н. Селезнев
Original Assignee
Закрытое акционерное общество "Рефарм"
Filing date
Publication date
Application filed by Закрытое акционерное общество "Рефарм" filed Critical Закрытое акционерное общество "Рефарм"
Priority to RU95120819A priority Critical patent/RU2101015C1/en
Priority claimed from RU95120819A external-priority patent/RU2101015C1/en
Application granted granted Critical
Publication of RU2101015C1 publication Critical patent/RU2101015C1/en
Publication of RU95120819A publication Critical patent/RU95120819A/en

Links

Claims (1)

1. Мазь для лечения неврологических заболеваний и заболеваний опорно-двигательного аппарата с болевым синдромом, включающаяся эффективный анальгезирующий препарат и основу, отличающаяся тем, что в качестве эффективного анальгезирующего препарата используют ксидифон при следующем соотношении компонентов, мас. %:
Ксидифон - 0,5 - 3
Основа - 99,5 - 97
2. Способ лечения неврологических заболеваний и заболеваний опорно-двигательного аппарата с болевым синдромом с применением препарата ксидифон, отличающаяся тем, что препарат применяют в форме мази, содержащей 0,5 - 3% ксидифона и 99,5 - 97 % мазевой основы, причем мазь наносят методом аппликации при плотности нанесения 1/5 - 1/6 г/см2 на поверхность кожи 1 раз в сутки и выдерживают в течение 1 - 1,5 ч при длительности процесса лечения 3 - 4 нед.1. Ointment for the treatment of neurological diseases and diseases of the musculoskeletal system with pain, including an effective analgesic drug and a base, characterized in that xidiphone is used as an effective analgesic drug in the following ratio of components, wt. %:
Xidiphon - 0.5 - 3
Base - 99.5 - 97
2. A method of treating neurological diseases and diseases of the musculoskeletal system with pain using the drug xidiphon, characterized in that the drug is used in the form of an ointment containing 0.5 to 3% xidiphon and 99.5 to 97% ointment base, and the ointment is applied by application at a density of application of 1/5 - 1/6 g / cm 2 to the skin surface 1 time per day and incubated for 1 - 1.5 hours with a duration of the treatment process of 3 - 4 weeks.
RU95120819A 1995-12-04 1995-12-04 External agent and a method of treatment of neurological and locomotor system disorders in combination with the pain syndrome and edema RU2101015C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU95120819A RU2101015C1 (en) 1995-12-04 1995-12-04 External agent and a method of treatment of neurological and locomotor system disorders in combination with the pain syndrome and edema

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU95120819A RU2101015C1 (en) 1995-12-04 1995-12-04 External agent and a method of treatment of neurological and locomotor system disorders in combination with the pain syndrome and edema

Publications (2)

Publication Number Publication Date
RU2101015C1 RU2101015C1 (en) 1998-01-10
RU95120819A true RU95120819A (en) 1998-02-10

Family

ID=20174560

Family Applications (1)

Application Number Title Priority Date Filing Date
RU95120819A RU2101015C1 (en) 1995-12-04 1995-12-04 External agent and a method of treatment of neurological and locomotor system disorders in combination with the pain syndrome and edema

Country Status (1)

Country Link
RU (1) RU2101015C1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6986884B2 (en) * 2002-09-04 2006-01-17 Rosenberg E William Composition and method for treating soft nails
RU2463346C2 (en) * 2010-12-13 2012-10-10 Федеральное государственное бюджетное учреждение "Московский научно-исследовательский институт педиатрии и детской хирургии" Министерства здравоохранения и социального развития Российской Федерации Method for increasing proliferative mitochondrial activity in cells
RU2598346C1 (en) * 2015-04-13 2016-09-20 Федеральное бюджетное учреждение науки "Федеральный научный центр медико-профилактических технологий управления рисками здоровью населения" (ФБУН "ФНЦ медико-профилактических технологий управления рисками здоровью населения") Method of treating and preventing dysmetabolic nephropathy in children associated with toxic action of cadmium, lead, chrome and phenol of anthropogenic origin
RU2643928C2 (en) * 2016-04-01 2018-02-06 Общество с ограниченной ответственностью "Институт фармацевтических реактивов РЕФАРМ" Medical and cosmetic means for external application

Similar Documents

Publication Publication Date Title
HUT59313A (en) Process for producing pharmaceutical composition comprising flupirtin as active ingredient and suitable for combatting muscular tensions
ATE178793T1 (en) L-DOPA ESTER CONTAINING COMPOSITION
CA2314326A1 (en) Transdermal therapeutic device and method with capsaicin and capsaicin analogs
NO152902C (en) METHOD OF ANALOGY FOR THE PREPARATION OF THERAPEUTIC ACTIVITY 1-ALKYL-2-AMINOTETRALIN DERIVATIVES
NZ303372A (en) Use of (s)-oxybutynin and (s)-desethyloxybutynin to treat urinary incontinence
CA2025078A1 (en) External Analgesic lotion and Method of Making
BE879173A (en) PROCESS FOR THE PREPARATION OF AN ALLERGEN TREATED WITH AN ALDEHYDE, PRODUCT OBTAINED AND ITS THERAPEUTIC APPLICATION
BE869721A (en) DERIVATIVES OF CYCLOALCOYLINDENEMETHYLPHENYLACETIC ACIDS, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
DE68926115D1 (en) METHOD FOR TREATING ACNE
ATE265851T1 (en) TREATMENT OF DISEASES CAUSED BY CYTOKINE GROWTH FACTOR
RU95120819A (en) EXTERNAL MEANS AND METHOD OF TREATMENT OF NEUROLOGICAL DISEASES AND DISEASES OF THE MOTOR-MOTOR APPARATUS WITH PAIN SYNDROME AND Puffiness
HU9303000D0 (en) Aryl-morpholine-derivatives and pharmaceutical compositions containing it and process for production thereof
MY104521A (en) Treatment of depression.
IL103799A (en) Fish production
FR2520739B1 (en) NEW INDOLEACETIC ESTER DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
FR2353544A1 (en) BENZYL ESTERS AND RELATED ESTERS OF 6,11-DIHYDRODIBENZ (B, E) OXEPINE-ACETIC ACIDS, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
FR2321282A1 (en) O-AMINOALKANOIC ACID ARYLAMIDES, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
BE888057A (en) 2-CYANOETHYL-2- (N-BENZOYLAMINO) ALKANOIC ACID DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
FR2604707B1 (en) PROCESS FOR THE PREPARATION OF AN ACTIVE THERAPEUTIC COMPOUND
FR2620439B1 (en) METHOD AND DEVICE FOR THE TREATMENT, BY METHANIC FERMENTATION, OF LIPIDIC WASTE WATER
HUT62789A (en) Process for producing pharmaceutical composition comprising r(+)-3-amino-1-hydroxypyrroliden-2-one as active ingredient and suitable for treating anxiety
BE888313A (en) DERIVATIVES OF BENZAMIOETHYLPHENOXYCYCLOHEXYLACETIC ACIDS, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION,
SE9000658D0 (en) METHOD FOR TREATMENT OF SLEEP APNOE
RU94002713A (en) Method for treating children possessing elongated qt interval syndrome
RU93046022A (en) METHOD FOR TREATMENT OF BRONCHOPNEMONIA OF CALVES